Neuropathy Congenital Hypomyelinating 2 C4722277
A rare inherited neuropathy present from birth where nerves lack normal protective coating. It causes severe muscle weakness and movement problems. Treatment involves physical therapy and supportive measures for breathing and nutrition.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Respiratory distress
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Severe neonatal hypotonia
(neurologic)Motor developmental delay
(neurologic)Areflexia
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Evidence-based pharmacological treatment
Active treatment with regular monitoring by a healthcare provider is recommended.
Neuromuscular Physical Therapy
Comprehensive physical therapy program focusing on strength maintenance, range of motion exercises, and functional mobility training to preserve motor abilities and prevent contractures.
Neuropathic Pain Management
Pharmacological approach using appropriate neuropathic pain agents to manage burning, tingling, and shooting pain associated with hypomyelinization. Regular reassessment of efficacy and side effects required.
Additional treatment options
Assistive Device Assessment and Provision
Comprehensive evaluation and provision of appropriate assistive devices including ankle-foot orthotics, walking aids, and adaptive equipment to enhance mobility and independence.
lifestyleMultidisciplinary Disease Monitoring
Regular monitoring through a coordinated care team including neurology, physiatry, and genetics to track disease progression, manage complications, and adjust treatment plans.
monitoringPsychological Support and Coping Strategies
Psychological counseling and support services to address the emotional impact of living with a chronic progressive neuropathy, including coping strategies for pain and disability.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Neuropathy Congenital Hypomyelinating 2 C4722277?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Neuropathy Congenital Hypomyelinating 2 C4722277. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy